Global Famciclovir API Supply, Demand and Key Producers, 2026-2032
Description
The global Famciclovir API market size is expected to reach $ 16.65 million by 2032, rising at a market growth of 2.2% CAGR during the forecast period (2026-2032).
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.
Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.
Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.
Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report studies the global Famciclovir API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Famciclovir API and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Famciclovir API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Famciclovir API total production and demand, 2021-2032, (KG)
Global Famciclovir API total production value, 2021-2032, (USD Million)
Global Famciclovir API production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (KG), (based on production site)
Global Famciclovir API consumption by region & country, CAGR, 2021-2032 & (KG)
U.S. VS China: Famciclovir API domestic production, consumption, key domestic manufacturers and share
Global Famciclovir API production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (KG)
Global Famciclovir API production by Type, production, value, CAGR, 2021-2032, (USD Million) & (KG)
Global Famciclovir API production by Application, production, value, CAGR, 2021-2032, (USD Million) & (KG)
This report profiles key players in the global Famciclovir API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, Olon, Fuan Pharmaceutical, Zhejiang Charioteer Pharmaceutical, Jialin Pharmaceutical, Zhejiang Hisun, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Famciclovir API market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (KG) and average price (US$/KG) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Famciclovir API Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Famciclovir API Market, Segmentation by Type:
Insourced
Outsourced
Others
Global Famciclovir API Market, Segmentation by Application:
Tablet Product
Capsule Product
Others
Companies Profiled:
Chongqing Shenghuaxi Pharma
Aurobindo Pharma Limited
Apotex Pharmachem
Changzhou Kony Pharma Co
Teva Pharmaceutical Industries
Olon
Fuan Pharmaceutical
Zhejiang Charioteer Pharmaceutical
Jialin Pharmaceutical
Zhejiang Hisun
Hetero
Key Questions Answered:
1. How big is the global Famciclovir API market?
2. What is the demand of the global Famciclovir API market?
3. What is the year over year growth of the global Famciclovir API market?
4. What is the production and production value of the global Famciclovir API market?
5. Who are the key producers in the global Famciclovir API market?
6. What are the growth factors driving the market demand?
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.
Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.
Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.
Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report studies the global Famciclovir API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Famciclovir API and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Famciclovir API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Famciclovir API total production and demand, 2021-2032, (KG)
Global Famciclovir API total production value, 2021-2032, (USD Million)
Global Famciclovir API production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (KG), (based on production site)
Global Famciclovir API consumption by region & country, CAGR, 2021-2032 & (KG)
U.S. VS China: Famciclovir API domestic production, consumption, key domestic manufacturers and share
Global Famciclovir API production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (KG)
Global Famciclovir API production by Type, production, value, CAGR, 2021-2032, (USD Million) & (KG)
Global Famciclovir API production by Application, production, value, CAGR, 2021-2032, (USD Million) & (KG)
This report profiles key players in the global Famciclovir API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, Olon, Fuan Pharmaceutical, Zhejiang Charioteer Pharmaceutical, Jialin Pharmaceutical, Zhejiang Hisun, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Famciclovir API market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (KG) and average price (US$/KG) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Famciclovir API Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Famciclovir API Market, Segmentation by Type:
Insourced
Outsourced
Others
Global Famciclovir API Market, Segmentation by Application:
Tablet Product
Capsule Product
Others
Companies Profiled:
Chongqing Shenghuaxi Pharma
Aurobindo Pharma Limited
Apotex Pharmachem
Changzhou Kony Pharma Co
Teva Pharmaceutical Industries
Olon
Fuan Pharmaceutical
Zhejiang Charioteer Pharmaceutical
Jialin Pharmaceutical
Zhejiang Hisun
Hetero
Key Questions Answered:
1. How big is the global Famciclovir API market?
2. What is the demand of the global Famciclovir API market?
3. What is the year over year growth of the global Famciclovir API market?
4. What is the production and production value of the global Famciclovir API market?
5. Who are the key producers in the global Famciclovir API market?
6. What are the growth factors driving the market demand?
Table of Contents
126 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
